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From 18th Pediatric Rheumatology European Society (PReS) Congress
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Background
To assess autoimmune response and H1N1 serology fol-
lowing influenza H1N1 vaccination in juvenile idiopathic
arthritis (JIA).
Methods
58 JIA patients were vaccinated with cepa A/California/
7/2009 (NYMC X-179A) anti-H1N1. All participants
received 1 dose of immunization, those <9yrs of age
received a second dose 3weeks apart. All sera were eval-
uated before and 3weeks after complete vaccination.
Serology against H1N1 virus was performed by hemag-
glutination inhibition antibody assay, antinuclear antibo-
dies (ANA) by IIF, IgM and IgG anticardiolipin (aCL)
by ELISA, and rheumatoid factor (RF) by latex fixation
test.
Results
Mean age of patients =23.9±9.5yrs, 38F:20M, mean dis-
ease duration=14.7±10.1yrs. Six(10%) had systemic, 33
(57%) poliarticular, 10(17%) oligoarticular and 9 (16%)
other JIA subtype. Sixteen were off drugs and 42 (72%)
under different drug treatments: 32(55%) using one
DMARD/IS, 10(17%) on 2 DMARDs/IS, 19(33%) anti-
malarials, 29(50%) MTX, 8(14%) sulfasalazine, 6(10%)
anti-TNFs, 4(7%) abatacept; no patient was using pre-
dnisone >0.5mg/kg/d. Seroprotection rates against
H1N1 influenza increased from 23 to 83% and serocon-
version rates were achieved in 78% JIA. Before vaccina-
tion 31(53.4%) of JIA patients were positive for ANA, 6
(10.3%) for RF, and 4(7%) for both IgM and IgG aCL.
After complete H1N1 vaccination, positivity for ANA
remained the same whereas one patient became negative
for IgG aCL, and another for RF, IgM and IgG aCL.
Only 1/58 (1.7%) patient turned positive for low titer
IgG aCL.
Conclusions
Except for 1 patient that became positive for low titer
IgG aCL, vaccination of JIA patients against pandemic
influenza A (H1N1) generated successful protective anti-
body production with short term safety profile.
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